chloroquine has been researched along with rifampin in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (8.62) | 18.7374 |
1990's | 2 (3.45) | 18.2507 |
2000's | 18 (31.03) | 29.6817 |
2010's | 28 (48.28) | 24.3611 |
2020's | 5 (8.62) | 2.80 |
Authors | Studies |
---|---|
Clark, AM; Dunbar, DC; Muhammad, I; Takamatsu, S; Walker, LA | 1 |
Gochfeld, DJ; Hamann, MT | 1 |
Gerena, L; Milhous, WK; Opsenica, D; Pocsfalvi, G; Solaja, BA; Terzić, N; Tinant, B | 1 |
Al-Said, MS; Dunbar, DC; El Sayed, KA; Hamann, MT; Higa, T; Kelly, M; Orabi, KY | 1 |
Hamann, MT; Mesecar, AD; Rao, KV; Santarsiero, BD; Schinazi, RF; Tekwani, BL | 1 |
Hamann, MT; Kasanah, N; Rao, KV; Schinazi, RF; Tekwani, BL; Wahyuono, S | 1 |
König, GM; Papendorf, O; Wright, AD | 1 |
Alonso, D; Donia, MS; Franzblau, SG; Garcia-Palomero, E; Hamann, MT; Khan, SI; Martinez, A; Medina, M; Peng, J; Rao, KV; Tekwani, BL; Wahyuono, S; Willett, KL | 1 |
Karmodiya, K; Mishra, S; Ramya, TN; Surolia, A; Surolia, N | 1 |
Dahl, EL; Rosenthal, PJ | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Brun, R; Franzblau, SG; Huang, Q; Kozikowski, AP; Mao, J; Wan, B; Wang, Y | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choo, YM; Doerksen, RJ; Gertsch, J; Hamann, MT; Jacob, MR; Khan, SI; Kudrimoti, S; Madgula, V; Mayer, AM; Odde, S; Peng, J; Pennaka, HK; Prasanna, S; Rao, KV; Tekwani, BL; Tu, LC; Wang, B | 1 |
Chibale, K; Franzblau, SG; Guantai, EM; Gut, J; Hans, RH; Lategan, C; Rosenthal, PJ; Smith, PJ; Wan, B | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Barazarte, A; Camacho, J; Charris, J; Gamboa, N; Gilman, R; Rodrigues, J; Rojas, R; Vaisberg, A | 1 |
Chibale, K; Franzblau, SG; Gut, J; Hans, RH; Rosenthal, PJ; van Helden, PD; Wan, B; Wiid, IJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chaturvedi, V; Chauhan, K; Chauhan, PM; Puri, SK; Saxena, J; Saxena, JK; Sharma, M; Singh, SV; Srivastava, K; Trivedi, P | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Kalaria, PN; Raval, DK; Satasia, SP | 1 |
Karad, SC; Purohit, VB; Raval, DK | 1 |
Bharate, SB; Khan, IA; Khan, SI; Singh, S; Vishwakarma, RA; Yadav, RR | 1 |
Bourguet-Kondracki, ML; Chan, ST; Copp, BR; Dalton, JP; Page, MJ; Pearce, AN; Taylor, RB; Valentin, A; Wang, J; Wiles, S | 1 |
Franzblau, SG; Le Roch, KG; Nieves, K; Prudhomme, J; Rodríguez, AD | 1 |
Karad, SC; Purohit, VB; Raval, DK; Thakkar, VR; Thakor, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Sankar, C; Umamatheswari, S | 1 |
Baell, J; Li, J; Nagalingam, G; Nguyen, N; Schneider, EK; Triccas, JA; Velkov, T; Wilson, DW | 1 |
Hoppe, H; Isaacs, M; Kaye, PT; Olawode, EO; Prinsloo, E; Seldon, R; Steenkamp, V; Tandlich, R; Warner, DF | 1 |
Baartzes, N; Chibale, K; Seldon, R; Smith, GS; Stringer, T; Taylor, D; Warner, DF; Wittlin, S | 1 |
Hoppe, HC; Isaacs, M; Kaye, PT; Krause, RWM; Manyeruke, MH; Seldon, R; Tshiwawa, T; Warner, DF | 1 |
Adhikari, N; Gaikwad, VR; Govindarajalu, G; Karale, UB; Krishna, EV; Krishna, VS; Misra, S; Rode, HB; Sijwali, PS; Sriram, D | 1 |
Boonlarppradab, C; Choowong, W; Kornsakulkarn, J; Saepua, S; Suriyachadkun, C; Thongpanchang, C | 1 |
Mason, CG | 1 |
Trautman, JR | 1 |
Artemenko, NK; Freidlin, IS; Lyzlova, SN; Nersesova, LS; Petrova, TA | 1 |
Benoliel, AM; Bongrand, P; Maurin, M; Raoult, D | 1 |
Youmans, AS; Youmans, GP | 1 |
Artemenko, NK; Freĭdlin, IS; Teĭber, EL; Voskresenskiĭ, AM | 1 |
Charoenlarp, P; Pukrittayakamee, S; Viravan, C; White, NJ; Wilson, RJ; Yeamput, C | 1 |
Bhat, M; Hickey, AJ | 1 |
Abdulah, MS; Hou, LJ; Nor, NM; Raju, SS; Ravichandran, M | 1 |
Chan, JC; Chau, CH; Chow, WS; Lam, KS; Lee, CH; Tso, AW; Yeung, CK; Yuen, MM | 1 |
Chen, Y; Huang, K; Jing, X; Lei, M; Liang, Y; Lin, D; Liu, J; Peng, S; Tao, E; Wu, X; Xiao, S; Yang, L; Zeng, Z; Zheng, D; Zhou, T | 1 |
Calender, A; Israel-Biet, D; Pacheco, Y; Valeyre, D | 1 |
Amro, L; Arjdal, B; Benali, SA; Bouaré, F; Etouche, FN; Ghannane, H; Hajhouji, F; Laghmari, M; Saidi, I; Tassi, N | 1 |
3 review(s) available for chloroquine and rifampin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Ocular accumulation and toxicity of certain systemically administered drugs.
Topics: Amitriptyline; Animals; Chloroquine; Cornea; Eye; Eye Diseases; Female; Haplorhini; Humans; Lens, Crystalline; Phenothiazines; Pregnancy; Retinal Diseases; Rifampin; Structure-Activity Relationship; Thioxanthenes; Time Factors | 1977 |
Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Autophagy; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Host-Pathogen Interactions; Humans; Isoniazid; Lung; Pandemics; Pneumonia, Viral; Pulmonary Edema; Rifampin; Sarcoidosis; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severity of Illness Index | 2020 |
55 other study(ies) available for chloroquine and rifampin
Article | Year |
---|---|
Antimalarial, cytotoxic, and antifungal alkaloids from Duguetia hadrantha.
Topics: Alkaloids; Animals; Antifungal Agents; Antimalarials; Antineoplastic Agents, Phytogenic; Brazil; Cell Adhesion; Cell Aggregation; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Paraguay; Plant Extracts; Plants, Medicinal; Plasmodium falciparum; Spectrophotometry, Ultraviolet; Tumor Cells, Cultured | 2001 |
Isolation and biological evaluation of filiformin, plakortide F, and plakortone G from the Caribbean sponge Plakortis sp.
Topics: Animals; Antimalarials; Bromobenzenes; Chromatography, High Pressure Liquid; Colonic Neoplasms; Dioxanes; Gas Chromatography-Mass Spectrometry; Hepatitis B; HIV; Humans; Jamaica; Lactones; Leukemia P388; Lung Neoplasms; Mice; Molecular Structure; Mycobacterium tuberculosis; Neoplasms, Unknown Primary; Nuclear Magnetic Resonance, Biomolecular; Plasmodium berghei; Plasmodium falciparum; Porifera; Spectrometry, Mass, Electrospray Ionization; Tumor Cells, Cultured | 2001 |
Mixed steroidal 1,2,4,5-tetraoxanes: antimalarial and antimycobacterial activity.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Chlorocebus aethiops; Crystallography, X-Ray; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Spectrometry, Mass, Electrospray Ionization; Spiro Compounds; Steroids; Structure-Activity Relationship; Vero Cells | 2002 |
Araguspongines K and L, new bioactive bis-1-oxaquinolizidine N-oxide alkaloids from Red Sea specimens of Xestospongia exigua.
Topics: Alkaloids; Animals; Antimalarials; Antitubercular Agents; Indian Ocean; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Plasmodium falciparum; Porifera; Quinolizines; Rifampin; Stereoisomerism | 2002 |
New manzamine alkaloids with activity against infectious and tropical parasitic diseases from an Indonesian sponge.
Topics: Alkaloids; Animals; Anti-HIV Agents; Antiprotozoal Agents; Carbazoles; Carbolines; Crystallography, X-Ray; Indoles; Indonesia; Inhibitory Concentration 50; Leishmania donovani; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Nucleosides; Porifera; Pyrroles; Stereoisomerism | 2003 |
Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases.
Topics: Alkaloids; Animals; Anti-HIV Agents; Anti-Infective Agents; Antimalarials; Antiprotozoal Agents; Carbolines; Indonesia; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Porifera | 2004 |
Ambigol C and 2,4-dichlorobenzoic acid, natural products produced by the terrestrial cyanobacterium Fischerella ambigua.
Topics: Animals; Antifungal Agents; Biphenyl Compounds; Carbazoles; Chlorobenzenes; Chlorobenzoates; Cyanobacteria; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Phenols; Switzerland; Trypanocidal Agents; Trypanosoma brucei rhodesiense | 2005 |
Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases.
Topics: Alzheimer Disease; Animals; Female; Glycogen Synthase Kinase 3; HIV-1; Humans; Indole Alkaloids; Indonesia; Inhibitory Concentration 50; Leishmania donovani; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oryzias; Plasmodium falciparum; Porifera; Structure-Activity Relationship | 2006 |
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.
Topics: Acetone; Animals; Antimalarials; Azithromycin; Cerulenin; Chloramphenicol; Clindamycin; Erythrocytes; Fatty Acids; Gene Dosage; Humans; Organelles; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Tetracycline; Thioctic Acid; Triclosan | 2007 |
Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Drug Resistance; Flow Cytometry; Green Fluorescent Proteins; Plasmodium falciparum; Protein Synthesis Inhibitors; Topoisomerase II Inhibitors | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles.
Topics: Antimalarials; Antitubercular Agents; Benzothiazoles; Drug Design; Isoxazoles; Models, Molecular; Mycobacterium tuberculosis; Phenylacetates; Stereoisomerism; Structure-Activity Relationship; Trypanocidal Agents | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections.
Topics: Animals; Anti-Infective Agents; Carbazoles; Cerebellar Diseases; Indole Alkaloids; Mice; Microbial Sensitivity Tests; Molecular Structure; Neurogenic Inflammation; Porifera; Stereoisomerism; Structure-Activity Relationship | 2010 |
Synthesis, antimalarial and antitubercular activity of acetylenic chalcones.
Topics: Alkynes; Antimalarials; Antitubercular Agents; Chalcones; Mycobacterium tuberculosis; Plasmodium falciparum | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Synthesis and biological evaluation of benzimidazole-5-carbohydrazide derivatives as antimalarial, cytotoxic and antitubercular agents.
Topics: Animals; Antimalarials; Antitubercular Agents; Benzimidazoles; Cell Line, Tumor; Drug Resistance, Multiple; Hemin; Hemoglobins; Humans; Hydrazines; Hydrolysis; Mice; Plasmodium | 2011 |
Novel thiolactone-isatin hybrids as potential antimalarial and antitubercular agents.
Topics: Animals; Antimalarials; Antitubercular Agents; Isatin; Lactones; Mycobacterium tuberculosis; Plasmodium falciparum; Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Synthesis and biological evaluation of a new class of 4-aminoquinoline-rhodanine hybrid as potent anti-infective agents.
Topics: Aminoquinolines; Animals; Anti-Infective Agents; Chlorocebus aethiops; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Parasitic Sensitivity Tests; Plasmodium falciparum; Rhodanine; Structure-Activity Relationship; Vero Cells | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymers; Pyrazoles; Quinolines; Structure-Activity Relationship | 2014 |
Design, synthesis and characterization of fluoro substituted novel pyrazolylpyrazolines scaffold and their pharmacological screening.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Structure-Activity Relationship | 2014 |
Synthesis, antimalarial and antitubercular activities of meridianin derivatives.
Topics: Animals; Antimalarials; Antitubercular Agents; Cell Line, Tumor; Humans; Indoles; Inhibitory Concentration 50; Plasmodium falciparum; Pyrimidines; Quantitative Structure-Activity Relationship; Sulfonamides | 2015 |
Biologically Active Acetylenic Amino Alcohol and N-Hydroxylated 1,2,3,4-Tetrahydro-β-carboline Constituents of the New Zealand Ascidian Pseudodistoma opacum.
Topics: Alkynes; Animals; Antimalarials; Carbolines; Chloroquine; Drug Resistance, Bacterial; Escherichia coli; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; New Zealand; Plasmodium falciparum; Staphylococcus aureus; Urochordata | 2016 |
Natural product-based synthesis of novel anti-infective isothiocyanate- and isoselenocyanate-functionalized amphilectane diterpenes.
Topics: Animals; Anti-Infective Agents; Biological Products; Cyanates; Diterpenes; Inhibitory Concentration 50; Isothiocyanates; Mycobacterium tuberculosis; Plasmodium falciparum; Porifera; Selenium Compounds | 2016 |
Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities.
Topics: Anti-Infective Agents; Antimalarials; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Plasmodium falciparum; Pyrazoles; Quinolines; Structure-Activity Relationship; Tuberculosis | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Synthesis, identification and in vitro biological evaluation of some novel quinoline incorporated 1,3-thiazinan-4-one derivatives.
Topics: Anti-Bacterial Agents; Antimalarials; Antitubercular Agents; Clostridium tetani; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship; Thiazines | 2017 |
Broad activity of diphenyleneiodonium analogues against Mycobacterium tuberculosis, malaria parasites and bacterial pathogens.
Topics: Animals; Bacteria; Community-Acquired Infections; Cross Infection; Gram-Negative Bacteria; Gram-Positive Bacteria; Malaria; Mycobacterium tuberculosis; Onium Compounds; Structure-Activity Relationship | 2018 |
Synthesis and biological evaluation of 2-chloro-3-[(thiazol-2-yl)amino]-1,4-naphthoquinones.
Topics: Humans; Molecular Structure; Naphthoquinones; Structure-Activity Relationship | 2019 |
Bioisosteric ferrocenyl aminoquinoline-benzimidazole hybrids: Antimicrobial evaluation and mechanistic insights.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Benzimidazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Ferrous Compounds; Malaria; Mice; Molecular Structure; Mycobacterium tuberculosis; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2019 |
Synthesis and biological evaluation of bis-N
Topics: Antifungal Agents; Antitubercular Agents; Catalytic Domain; Coumarins; HeLa Cells; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Hydrazines; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Protein Binding; Trypanocidal Agents; Trypanosoma brucei brucei | 2020 |
Synthesis and efficacy of pyrvinium-inspired analogs against tuberculosis and malaria pathogens.
Topics: Antimalarials; Antitubercular Agents; Dose-Response Relationship, Drug; Malaria, Falciparum; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrvinium Compounds; Structure-Activity Relationship; Tuberculosis | 2020 |
Antimicrobial and Cytotoxic Angucyclic Quinones from
Topics: Actinomadura; Anti-Infective Agents; Antineoplastic Agents; Cell Line, Tumor; Humans; Magnetic Resonance Spectroscopy; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolones | 2021 |
Treatment of Hansen's disease.
Topics: Chloroquine; Clofazimine; Dapsone; Drug Resistance, Microbial; Erythema Nodosum; Humans; Leprosy; Prednisone; Rifampin; Thalidomide | 1976 |
[Changes in the functional activity of macrophages, their morphology and metabolism under the influence of several biologically active substances].
Topics: Ascorbic Acid; Carbon Radioisotopes; Cathepsins; Chloramphenicol; Chloroquine; Creatine Kinase; Culture Techniques; Cycloheximide; Dactinomycin; Lipopolysaccharides; Lysine; Macrophages; Orotic Acid; Peritoneum; Phagocytosis; Protein Biosynthesis; Puromycin; Rifampin; RNA; Tetracycline; Uridine | 1975 |
Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm.
Topics: Amantadine; Ammonium Chloride; Animals; Anti-Bacterial Agents; Cell Line; Chloroquine; Coxiella burnetii; Doxycycline; Hydrogen-Ion Concentration; Lysosomes; Macrophages; Mice; Pefloxacin; Phagocytosis; Rifampin | 1992 |
The effect of metabolic inhibitors and hydroxylamine on the immune response in mice to mycobacterial ribonucleic acid vaccines.
Topics: Animals; Antibody Formation; Antimetabolites; Bacterial Vaccines; Chloramphenicol; Chloroquine; Cycloheximide; Dactinomycin; Ethidium; Flavins; Floxuridine; Hemagglutination Tests; Hydroxylamines; Male; Mice; Mycobacterium tuberculosis; Rifampin; RNA, Bacterial; Streptomycin; Vaccination | 1974 |
[Changes in the immunologic response to bacteriophage T2 due to the transcription inhibitors actinomycin D, olivomycin, rifomycin and chloroquine].
Topics: Animals; Antibody Formation; Antigens, Viral; Chloroquine; Coliphages; Dactinomycin; Immunization; Mice; Oligomycins; Rifampin | 1972 |
Antimalarial effects of rifampin in Plasmodium vivax malaria.
Topics: Adolescent; Adult; Animals; Chloroquine; Drug Therapy, Combination; Humans; Malaria, Vivax; Male; Middle Aged; Pilot Projects; Plasmodium vivax; Primaquine; Rifampin | 1994 |
Effect of chloroquine on phagolysosomal fusion in cultured guinea pig alveolar macrophages: implications in drug delivery.
Topics: Animals; Antibiotics, Antitubercular; Cells, Cultured; Chloroquine; Dextrans; Drug Synergism; Fluorescent Dyes; Guinea Pigs; Lysosomes; Macrophages, Alveolar; Microscopy, Fluorescence; Microspheres; Phagosomes; Rhodamines; Rifampin | 2000 |
Rifampicin antagonizes the effect of choloroquine on chloroquine-resistant Plasmodium berghei in mice.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Therapy, Combination; Malaria; Mice; Parasitemia; Plasmodium berghei; Rifampin | 2004 |
A man with a blistering eruption and tuberculosis.
Topics: Antimalarials; Antitubercular Agents; Chloroquine; Diagnosis, Differential; Drug Therapy, Combination; Feces; Hepatitis C; Humans; Iron Overload; Male; Middle Aged; Phlebotomy; Photosensitivity Disorders; Porphyria Cutanea Tarda; Porphyrins; Rifampin; Risk Factors; Skin Diseases, Vesiculobullous; Tuberculosis, Pulmonary | 2012 |
Rifampicin inhibits rotenone-induced microglial inflammation via enhancement of autophagy.
Topics: Analysis of Variance; Antirheumatic Agents; Autophagy; Cell Line, Tumor; Chloroquine; Coculture Techniques; Humans; Insecticides; Interleukin-1beta; Interleukin-6; Membrane Potential, Mitochondrial; Microglia; Microscopy, Electron, Transmission; Mitochondria; Neuroblastoma; Neuroprotective Agents; Reactive Oxygen Species; Rifampin; Rotenone | 2017 |
Unusual association of COVID-19, pulmonary tuberculosis and human immunodeficiency virus, having progressed favorably under treatment with chloroquine and rifampin.
Topics: Adult; Antimalarials; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Diagnosis, Differential; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Rifampin; SARS-CoV-2; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2020 |